Community/Retail

Pharmacy Times will be covering the National Association of Chain Drug Stores (NACDS) Total Store Expo, taking place in Boston from August 27 to 29, 2022.

Jake Nichols, PharmD, CEO, president, and co-founder of Renovo Health, discusses the stigma around drug diversion and the best ways to address and fight that stigma.

Executives from CVS Health said they have multiple pathways in achieving a push to establish primary care services, provider enablement, and home health.

Investigators also report that the therapy could mimic the efficacy of olanzapine but cancelled out the medication-induced weight gain, improving symptoms and outcomes.

Investigators report that while lateral flow tests do not detect the start of infectiousness well, they can identify individuals who will not infect others and can safely leave isolation.

Dundee Pharmacy’s compliance packaging encourages patients to stay adherent to their medications.

Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, said the company is in early stages of development for a combined mRNA vaccine for influenza, COVID-19, and RSV.

Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.

Triple Paste Ointment is used to treat rashes, including diaper rash.

Overall low awareness of the Omicron variant infection contributed to high transmission rates and rapid spread of SARS-CoV-2 in communities.

Jake Nichols, PharmD, CEO, president, and co-founder of Renovo Health, discusses his experience with drug diversion and addiction.

This month's rx product news features Skyrizi (AbbVie), Myfembree (Myovant Sciences, Pfizer), and Dupixent (Regeneron Pharmaceuticals).

The Total Store Expo is taking place in Boston from August 27 through 29, 2022.

Narcissistic leaders have a negative impact on the culture of their organization as their conduct and management style induces fear.

The announcement marks the first protein-based COVID-19 vaccine authorized in the United States for this patient population.

Decision in favor of FDA partially clarifies a somewhat gray area of the law regarding medications.

University of Minnesota Medical School Analysis shows comparison with fluvoxamine and ivermectin in a double-blinded, placebo-controlled, randomized study.

The American Heart Association includes 6 conditions and indicates that men’s and women’s experiences may differ.

Omnipod 5 is an automated, tubeless insulin dispensing system that allows for continuous infusion and bolus dosing as needed.

Aobbiy is a lung expansion and mucus relief device that aids in mucus removal to help clear the airway.

Auvelity uses the first new oral mechanism of action for major depressive disorder in more than 60 years.

Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, discussed how mRNA vaccines could change the treatment landscape for respiratory illnesses.

Douglas Hoey, PharmD, MBA, CEO of National Community Pharmacists Association (NCPA), discusses potential causes and solutions for the current staffing issues facing so many community pharmacies.

Treatment with empagliflozin also found to improve cardiac geometry, myocardial mechano-energetic efficiency, and cardiac function.

Resources for health care professionals include FDA’s patient eligibility screening checklist tool for prescribers.

Using specific data and technology can help advance targeted recruitment goals for trials.

Broncochem is an expectorant syrup to help cough symptoms.

A study suggests the paradigm of retail pharmacy is shifting, as customers are wanting more health and wellness-centered pharmacies as well as digital services.

Adalimumab-bwwd is a tumor necrosis factor blocker indicated for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, and plaque psoriasis.

In a recent survey, community pharmacists discussed current hardships in the industry, which include low supply, increasing costs, and trouble filling necessary positions.